SHBG Is an Important Factor in Stemness Induction of Cells by DHT In Vitro and Associated with Poor Clinical Features of Prostate Carcinomas

• Yuanyuan Ma,

  Affiliations Department of Pathology, The Norwegian Radium Hospital, Institute of Clinical Medicine, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China

  ⨯
• Dongming Liang,

  Affiliation Department of Pathology, The Norwegian Radium Hospital, Institute of Clinical Medicine, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Jian Liu,

  Affiliation Department of Pathology, The Norwegian Radium Hospital, Institute of Clinical Medicine, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Jian-Guo Wen,

  Affiliation Department of Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan, China

  ⨯
• Einar Servoll,

  Affiliation Department of Surgery, Soerlandet Hospital, Arendal, Norway

  ⨯
• Gudmund Waaler,

  Affiliation Department of Surgery, Soerlandet Hospital, Arendal, Norway

  ⨯
• Thorstein Sæter,

  Affiliation Department of Surgery, Soerlandet Hospital, Arendal, Norway

  ⨯
• Karol Axcrona,

  Affiliation Departments of Urology, The Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Oslo, Norway

  ⨯
• Ljiljana Vlatkovic,

  Affiliation Department of Pathology, The Norwegian Radium Hospital, Institute of Clinical Medicine, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Ulrika Axcrona,

  Affiliation Department of Pathology, The Norwegian Radium Hospital, Institute of Clinical Medicine, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Elisabeth Paus,

  Affiliation Department of Medical Biochemistry, Oslo University Hospital, University of Oslo, Oslo, Norway

  ⨯
• Yue Yang,

  Affiliation Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China

  ⨯
• Zhiqian Zhang,

  Affiliation Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Cell Biology, Peking University Cancer Hospital & Institute, Beijing, China

  ⨯
• Gunnar Kvalheim,

  Affiliation Departments of Cell Therapy, The Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Oslo, Norway

  ⨯
• Jahn M. Nesland,

  Affiliation Department of Pathology, The Norwegian Radium Hospital, Institute of Clinical Medicine, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
•  [ ... ],
• Zhenhe Suo

  * E-mail: zhenhes@medisin.uio.no

  Affiliations Department of Pathology, The Norwegian Radium Hospital, Institute of Clinical Medicine, Oslo University Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan, China

  ⨯
• [ view all ]
• [ view less ]